Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Global Outlook and Forecast 2025-2032

The global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics market size was estimated at USD 1120 million in 2024 and is projected to reach USD 1990.82 million by 2032, exhibiting a CAGR of 6.60% during the forecast period.

North America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics market size was estimated at USD 325.79 million in 2024, at a CAGR of 5.66% during the forecast period of 2025 through 2032. 

Report Overview

Non-alcoholic steatohepatitis (NASH) is a form of liver disease characterized by inflammation and liver cell damage caused by the accumulation of fat in the liver. It is often associated with obesity, insulin resistance, and metabolic syndrome. As there is currently no approved specific therapy for NASH, treatment primarily focuses on managing the underlying risk factors and minimizing liver damage.

Market Segmentation (by Type)

• Imaging Techniques

• Diagnostic Tests

• Biopsy

• Others

Market Segmentation (by Application)

• Hospital Pharmacy

• Online Channels

• Retail Channels

• Others

Get free sample of this report at : https://www.24marketresearch.com/download-free-sample/8027556/global-nonalcoholic-steatohepatitis-therapeutics-diagnostics-2025-2032-90